These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Studies of the significance of the electrocardiographic changes produced by orthostatism in patients with neurocirculatory asthenia]. Zamfirescu NR; Petrea S; Ionescu V; Adamache A Fiziol Norm Patol; 1973; 19(5):405-20. PubMed ID: 4148175 [No Abstract] [Full Text] [Related]
4. [Propranolol test in the differential diagnosis of post-exercise ECG changes in women with neurocirculatory asthenia]. Dvorák I; Zemánková J; Blaha M; Bravený P; Nĕmcová H; Kubesová H Vnitr Lek; 1983 May; 29(5):432-8. PubMed ID: 6880059 [No Abstract] [Full Text] [Related]
5. [Efficacy of treating patients with vegetative and vascular crises of a neurotic nature (comparative electrophysiologic study)]. Veĭn AM; Tabeeva GR; Iakhno NN Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(5):684-8. PubMed ID: 2874677 [TBL] [Abstract][Full Text] [Related]
6. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography]. Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668 [No Abstract] [Full Text] [Related]
7. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum). Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634 [TBL] [Abstract][Full Text] [Related]
8. [Neurocirculatory dystonia]. Makolkin VI Ter Arkh; 1995; 67(6):66-70. PubMed ID: 7667788 [No Abstract] [Full Text] [Related]
9. [A multimodality method for the rehabilitation of myocardial infarct patients with a hyperkinetic type of hemodynamics during convalescence]. Novikov SA Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (6):8-10. PubMed ID: 7762214 [TBL] [Abstract][Full Text] [Related]
10. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration. Szám I; Büky P; Gulyás A; Sinkovics M Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761 [TBL] [Abstract][Full Text] [Related]
11. [Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory dystonia of the cardiac type]. Orlov LL; Makoeva LD; Glezer MG; Memetov KA; Belinskaia TF; Arzhanenko OM Kardiologiia; 1991 Feb; 31(2):36-9. PubMed ID: 2041288 [No Abstract] [Full Text] [Related]
13. [Clinical symptoms and the diagnosis of the hyperkinetic cardiac syndrome]. Abbakumov SA; Bazhanov NN; Kapeliovich MR Kardiologiia; 1980 Nov; 20(11):36-9. PubMed ID: 6108381 [TBL] [Abstract][Full Text] [Related]
14. [Use of sotalol in hyperkinetic heart syndrome: clinical evaluation and Holter dynamic electrocardiography]. Gallo G; Foresti A Cardiologia; 1984; 29(3-4):237-54. PubMed ID: 6541942 [No Abstract] [Full Text] [Related]
15. Effect of tolamolol versus propranolol on systolic time intervals in angina. Aronow WS; Vawter M; Spivack N; Warren M; Laverty W Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826 [No Abstract] [Full Text] [Related]
16. [Obzidan test in the practice of medico-flight expertise]. Kondrakov VM; Arsen'eva LI Voen Med Zh; 1976 Dec; (12):72-4. PubMed ID: 14444 [No Abstract] [Full Text] [Related]
17. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type]. Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB Sov Med; 1988; (7):96-9. PubMed ID: 3067385 [No Abstract] [Full Text] [Related]
18. [Some questions on the functional pathology of the cardiovascular system (review of the literature)]. Ostapiuk FE; Sotskova TV Ter Arkh; 1974; 46(10):113-8. PubMed ID: 4610861 [No Abstract] [Full Text] [Related]
19. Editorial: Da Costa syndrome revisited. Vaisrub S JAMA; 1975 Apr; 232(2):164. PubMed ID: 235031 [No Abstract] [Full Text] [Related]